AAAAAA

   
Results: 1-13 |
Results: 13

Authors: BEASLEY CM SAYLER ME KIESLER GM POTVIN JH SANGER TM TOLLEFSON GD
Citation: Cm. Beasley et al., THE INFLUENCE OF PHARMACOTHERAPY ON SELF-DIRECTED AND EXTERNALLY-DIRECTED AGGRESSION IN SCHIZOPHRENIA, Schizophrenia research, 29(1-2), 1998, pp. 28-28

Authors: TOLLEFSON GD SAYLER ME BLOMGREN SL
Citation: Gd. Tollefson et al., THE COURSE OF PSYCHOMOTOR AGITATION DURING PHARMACOTHERAPY OF DEPRESSION - ANALYSIS FROM DOUBLE-BLIND, CONTROLLED TRIALS, Biological psychiatry, 41, 1997, pp. 334-334

Authors: SAYLER ME STREET JS BOSOMWORTH JC POTVIN JH KOTSANOS JG
Citation: Me. Sayler et al., ANALYSIS OF MORTALITY IN PERGOLIDE-TREATED PATIENTS WITH PARKINSONS-DISEASE, Neuroepidemiology, 15(1), 1996, pp. 26-32

Authors: GOLDSTEIN DJ RAMPEY AH ROBACK PJ WILSON MG HAMILTON SH SAYLER ME TOLLEFSON GD
Citation: Dj. Goldstein et al., EFFICACY AND SAFETY OF LONG-TERM FLUOXETINE TREATMENT OF OBESITY - MAXIMIZING SUCCESS, Obesity research, 3, 1995, pp. 481-490

Authors: GOLDSTEIN DJ SAYLER ME RAMPEY AH ROBACK PJ
Citation: Dj. Goldstein et al., FLUOXETINE THERAPY IN PATIENTS WITH OBESITY AND INSULIN-DEPENDENT DIABETES-MELLITUS, Clinical pharmacology and therapeutics, 57(2), 1995, pp. 200-200

Authors: SAYLER ME GOLDSTEIN DJ ROBACK PJ ATKINSON RL
Citation: Me. Sayler et al., EVALUATING SUCCESS OF WEIGHT-LOSS PROGRAMS, WITH AN APPLICATION TO FLUOXETINE WEIGHT-REDUCTION CLINICAL-TRIAL DATA, International journal of obesity, 18(11), 1994, pp. 742-751

Authors: SAYLER ME GOLDSTEIN DJ ROBACK PJ ATKINSON RL
Citation: Me. Sayler et al., EVALUATING SUCCESS OF WEIGHT-LOSS PROGRAMS, WITH AN APPLICATION TO FLUOXETINE WEIGHT-REDUCTION CLINICAL-TRIAL DATA, International journal of obesity, 18(11), 1994, pp. 742-751

Authors: TOLLEFSON GD GREIST JH JEFFERSON JW HEILIGENSTEIN JH SAYLER ME TOLLEFSON SL KOBACK K
Citation: Gd. Tollefson et al., IS BASE-LINE AGITATION A RELATIVE CONTRAINDICATION FOR A SELECTIVE SEROTONIN REUPTAKE INHIBITOR - A COMPARATIVE TRIAL OF FLUOXETINE VERSUS IMIPRAMINE, Journal of clinical psychopharmacology, 14(6), 1994, pp. 385-391

Authors: PANDE AC SAYLER ME
Citation: Ac. Pande et Me. Sayler, ADVERSE EVENTS AND TREATMENT DISCONTINUATIONS IN FLUOXETINE CLINICAL-TRIALS (VOL 8, PG 268, 1993), International clinical psychopharmacology, 9(2), 1994, pp. 134-134

Authors: TOLLEFSON GD HOLMAN SL SAYLER ME POTVIN JH
Citation: Gd. Tollefson et al., FLUOXETINE, PLACEBO, AND TRICYCLIC ANTIDEPRESSANTS IN MAJOR DEPRESSION WITH AND WITHOUT ANXIOUS FEATURES, The Journal of clinical psychiatry, 55(2), 1994, pp. 50-59

Authors: PANDE AC SAYLER ME
Citation: Ac. Pande et Me. Sayler, SEVERITY OF DEPRESSION AND RESPONSE TO FLUOXETINE, International clinical psychopharmacology, 8(4), 1993, pp. 243-245

Authors: PANDE AC SAYLER ME
Citation: Ac. Pande et Me. Sayler, ADVERSE EVENTS AND TREATMENT DISCONTINUATIONS IN FLUOXETINE CLINICAL-TRIALS, International clinical psychopharmacology, 8(4), 1993, pp. 267-269

Authors: BEASLEY CM SAYLER ME POTVIN JH
Citation: Cm. Beasley et al., FLUOXETINE VERSUS AMITRIPTYLINE IN THE TREATMENT OF MAJOR DEPRESSION - A MULTICENTER TRIAL, International clinical psychopharmacology, 8(3), 1993, pp. 143-149
Risultati: 1-13 |